Assertio Therapeutics, Inc.
Rasmiy reyestr maʼlumotlari
0obunachi
2018asos solingan
Assertio Therapeutics, Inc. haqida
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Bosh qarorgoh251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Asos solingan2018
StatusFaol
Patentlar1 ta patent
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Sharhlar
Hali sharh yoʻq. Assertio Therapeutics, Inc. bilan ishlaganmisiz? Tajribangizni birinchi boʻlib ulashing.
Huquqiy maʼlumot
| Yuridik nom | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20GLEIF da koʻrish ↗ |
| Roʻyxatdagi manzil | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Status | Faol |
Manbalar: GLEIF · 16-Oktabr, 2026-yil da yangilangan
Aloqa va havolalar
Joylashuv
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Bu sizning kompaniyangizmi?
Logotip, mahsulotlar, suratlar va ishlarni qoʻshish hamda sharhlarga javob berish uchun bu sahifani bepul egallang.
Bu sahifani egallangBogʻlanish, ishga olish va oʻsish uchun Heelky ga qoʻshiling
Odamlarga yozish, ishlarga ariza berish va missiya joylash uchun bepul hisob yarating.
Hozir qoʻshiling — bepul